SERPINE1 and thrombophilia: With the gradual cessation of bleeding, combined with the supplementation of clotting substrates, and the inhibition of fibrinolysis by the production of thrombin-induced plasminogen activator inhibitor-1 (PAI-1), which leads to the conversion to hypercoagulation.